Federal Register / Vol. 79, No. 116 / Tuesday, June 17, 2014 / Notices 34551 

1The record is defined in sec. 207.2(f) of the 

Commission’s Rules of Practice and Procedure (19 

CFR § 207.2(f)). 

2Commissioner Rhonda K. Schmidtlein did not 

participate in the vote. 

service list), and a certificate of service 

must be timely filed. The Secretary will 

not accept a document for filing without 

a certificate of service. 

Authority: This review is being conducted 

under authority of title VII of the Tariff Act 

of 1930; this notice is published pursuant to 

section 207.62 of the Commission’s rules. 

By order of the Commission. 

Issued: June 12, 2014. 

Lisa R. Barton, 

Secretary to the Commission. 

[FR Doc. 2014–14148 Filed 6–16–14; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 731–TA–991 (Second 

Review)] 

Silicon Metal From Russia 

Determination 

On the basis of the record 1 developed 

in the subject five-year review, the 

United States International Trade 

Commission (Commission) determines, 

pursuant to section 751(c) of the Tariff 

Act of 1930 (19 U.S.C. § 1675(c)), that 

revocation of the antidumping duty 

order would be likely to lead to 

continuation or recurrence of material 

injury to an industry in the United 

States within a reasonably foreseeable 

time.2

Background 

The Commission instituted this 

review on June 3, 2013 (78 FR 33064) 

and determined on September 6, 2013 

that it would conduct a full review (78 

FR 61384, October 3, 2013). Notice of 

the scheduling of the Commission’s 

review and of a public hearing to be 

held in connection therewith was given 

by posting copies of the notice in the 

Office of the Secretary, U.S. 

International Trade Commission, 

Washington, DC, and by publishing the 

notice in the Federal Register on 

December 19, 2013 (78 FR 76856). The 

hearing was cancelled, on April 7, 2014 

(79 FR 19921, April 10, 2014). 

The Commission completed and filed 

its determination in this review on June 

11, 2014. The views of the Commission 

are contained in USITC Publication 

4471 (June 2014), entitled Silicon Metal 

from Russia: Investigation No. 731–TA– 

991 (Second Review). 

By order of the Commission. 

Issued: June 12, 2014. 

Lisa R. Barton, 

Secretary to the Commission. 

[FR Doc. 2014–14146 Filed 6–16–14; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: CATALENT CTS, LLC 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration in 

accordance with 21 CFR 1301.34(a) on 

or before July 17, 2014. Such persons 

may also file a written request for a 

hearing on the application pursuant to 

21 CFR 1301.43 on or before July 17, 

2014. 

ADDRESS: Written comments should be 

sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/ODW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, and 

dispensers of controlled substances 

(other than final orders in connection 

with suspension, denial, or revocation 

of registration) has been redelegated to 

the Deputy Assistant Administrator of 

the DEA Office of Diversion Control 

(‘‘Deputy Assistant Administrator’’) 

pursuant to sec. 7(g) of 28 CFR pt. 0, 

subpt. R, App. 

In accordance with 21 CFR 

1301.34(a), this is notice that on May 7, 

2014, Catalent CTS, LLC, 10245 

Hickman Mills Drive, Kansas City, 

Missouri 64137, applied to be registered 

as an importer of the following basic 

classes of controlled substances: 

Controlled substance Schedule 

Marihuana (7360) ......................... I 

Poppy Straw Concentrate (9670) II 

The company plans to import a 

finished pharmaceutical product 

containing cannabis extracts in dosage 

form for a clinical trial study. 

In reference to drug code 7360, the 

company plans to import a synthetic 

cannabidiol. This compound is listed 

under drug code 7360. No other activity 

for this drug code is authorized for this 

registration. 

In addition, the company plans to 

import an ointment for the treatment of 

wounds which contain trace amounts of 

the controlled substances normally 

found in poppy straw concentrate for 

packaging and labeling to be used in 

clinical trials. 

Comments and requests for hearings 

on applications to import narcotic raw 

material are not appropriate. 72 FR 3417 

(January 25, 2007). 

Dated: June 10, 2014. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2014–14123 Filed 6–16–14; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: ALKERMES GAINESVILLE 

LLC 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration in 

accordance with 21 CFR 1301.34(a) on 

or before July 17, 2014. Such persons 

may also file a written request for a 

hearing on the application pursuant to 

21 CFR 1301.43 on or before July 17, 

2014. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/ODW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, and 


tkelley on DSK3SPTVN1PROD with NOTICES